K
Ki Woong Sung
Researcher at Samsung Medical Center
Publications - 192
Citations - 3457
Ki Woong Sung is an academic researcher from Samsung Medical Center. The author has contributed to research in topics: Transplantation & Autologous stem-cell transplantation. The author has an hindex of 26, co-authored 179 publications receiving 2925 citations. Previous affiliations of Ki Woong Sung include Sungkyunkwan University.
Papers
More filters
Journal ArticleDOI
Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues
Keon Hee Yoo,In Keun Jang,Myoung Woo Lee,Hyo Eun Kim,Mal Sook Yang,Young-Woo Eom,Jong Eun Lee,Young-Jin Kim,Seong Kyu Yang,Hye Lim Jung,Ki Woong Sung,Cheol Woo Kim,Hong Hoe Koo +12 more
TL;DR: Findings suggest that MSCs derived from AT, CB, or WJ could be substituted for BM-MSCs for treatment of allogeneic conflicts.
Journal ArticleDOI
Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell.
Dong Hyun Kim,Keon Hee Yoo,Kyung-Suk Choi,Jaewon Choi,Sang Yun Choi,Sung-Eun Yang,Yoon-Sun Yang,Ho Joon Im,Kye Hyun Kim,Hye Lim Jung,Ki Woong Sung,Hong Hoe Koo +11 more
TL;DR: Using RT-PCR analysis, the expression levels of cytokines and growth factors from MSCs and their differentiated cell types, including osteoblasts, adipocytes and endothelial cells are examined to help determine future clinical applications of MSCS and their derivatives for cell therapy.
Journal ArticleDOI
Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γ
Dae Seong Kim,In Keun Jang,Myoung Woo Lee,Young Jong Ko,Doo-Hoon Lee,Ji Won Lee,Ki Woong Sung,Hong Hoe Koo,Hong Hoe Koo,Keon Hee Yoo,Keon Hee Yoo +10 more
TL;DR: Infusion of MSCs primed with IFN-γ significantly reduced the symptoms of graft-versus-host disease (GVHD) in NOD-SCID mice, thereby increasing survival rate when compared with naïve MSC-infused mice.
Journal ArticleDOI
MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7
Seok-Jun Kim,Ji Young Shin,Kang-Duck Lee,Young-Ki Bae,Ki Woong Sung,Seok Jin Nam,Kyung-Hee Chun +6 more
TL;DR: The results from the present study suggest that targeting of CCL21-CCR7 signaling is a valid approach for breast cancer therapy and that let-7a directly binds to the 3'UTR of CCR7 and blocks its protein expression, thereby suppressing migration and invasion of human breast cancer cells.
Journal ArticleDOI
Development of microRNA-145 for therapeutic application in breast cancer.
Seok-Jun Kim,Ji-Sun Oh,Ji-Young Shin,Kang-Duck Lee,Ki Woong Sung,Seok Jin Nam,Kyung-Hee Chun +6 more
TL;DR: It is demonstrated that miR-145 suppresses tumor growth by inhibition of multiple tumor survival effectors, and more it is suppose that mi R-145 is potentially useful in the therapy of breast cancers.